Targeted Protein Degradation by Chimeric Small Molecules, PROTACs and SNIPERs

被引:35
|
作者
Naito, Mikihiko [1 ]
Ohoka, Nobumichi [1 ]
Shibata, Norihito [1 ]
Tsukumo, Yoshinori [1 ]
机构
[1] Natl Inst Hlth Sci, Lab Mol Target & Gene Therapy Prod, Kawasaki, Kanagawa, Japan
来源
FRONTIERS IN CHEMISTRY | 2019年 / 7卷
基金
日本学术振兴会;
关键词
PROTAC; SNIPER; E3; modulator; ubiquitin; proteasome; protein degradation; SELECTIVE DEGRADATION; INDUCE DEGRADATION; KNOCKDOWN; UBIQUITINATION; INHIBITORS; DESIGN; LIGAND; TIR1;
D O I
10.3389/fchem.2019.00849
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Technologies that induce targeted protein degradation by small molecules have been developed recently. Chimeric small molecules such as Proteolysis Targeting Chimeras (PROTACs) and Specific and Non-genetic IAP-dependent Protein Erasers (SNIPERs), and E3 modulators such as thalidomides, hijack the cellular machinery for ubiquitylation, and the ubiquitylated proteins are subjected to proteasomal degradation. This has motivated drug development in industry and academia because "undruggable targets" can now be degraded by targeted protein degradation.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Targeted Protein Degradation: An Emerging Therapeutic Strategy in Cancer
    Barghout, Samir H.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2021, 21 (02) : 214 - 230
  • [42] A Phenotypic Approach for the Identification of New Molecules for Targeted Protein Degradation Applications
    Stacey, Peter
    Lithgow, Hannah
    Lewell, Xiao
    Konopacka, Agnieszka
    Besley, Stephen
    Green, Georgina
    Whatling, Ryan
    Law, Robert
    Roeth, Sascha
    Sapkota, Gopal P.
    Smith, Ian E. D.
    Burley, Glenn A.
    Harling, John
    Benowitz, Andrew B.
    Queisser, Markus A.
    Muelbaier, Marcel
    SLAS DISCOVERY, 2021, 26 (07) : 885 - 895
  • [43] Targeted intracellular protein degradation induced by a small molecule: En route to chemical proteomics
    Schneekloth, Ashley R.
    Pucheault, Mathieu
    Tae, Hyun Seop
    Crews, Craig M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (22) : 5904 - 5908
  • [44] PROTAC: An Effective Targeted Protein Degradation Strategy for Cancer Therapy
    Qi, Si-Min
    Dong, Jinyun
    Xu, Zhi-Yuan
    Cheng, Xiang-Dong
    Zhang, Wei-Dong
    Qin, Jiang-Jiang
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [45] Target protein degradation by protacs: A budding cancer treatment strategy
    Choudhary, Diksha
    Kaur, Amritpal
    Singh, Pargat
    Chaudhary, Gaurav
    Kaur, Rajwinder
    Bayan, Mohammad F.
    Chandrasekaran, Balakumar
    Marji, Saeed M.
    Ayman, Reema
    PHARMACOLOGY & THERAPEUTICS, 2023, 250
  • [46] Proteolysis targeting chimeras (PROTACs) come of age: entering the third decade of targeted protein degradation
    Bond, Michael J.
    Crews, Craig M.
    RSC CHEMICAL BIOLOGY, 2021, 2 (03): : 725 - 742
  • [47] Targeted protein knockdown using small molecule degraders
    Raina, Kanak
    Crews, Craig M.
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2017, 39 : 46 - 53
  • [48] Homobivalent, Trivalent, and Covalent PROTACs: Emerging Strategies for Protein Degradation
    Yan, Jianyu
    Li, Tengfei
    Miao, Zhenyuan
    Wang, Pei
    Sheng, Chunquan
    Zhuang, Chunlin
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, : 8798 - 8827
  • [49] Targeted protein degradation: current molecular targets, localization, and strategies
    Pliatsika, Dimanthi
    Blatter, Cindy
    Riedl, Rainer
    DRUG DISCOVERY TODAY, 2024, 29 (11)
  • [50] Discovery of Small Molecules that Induce the Degradation of Huntingtin
    Tomoshige, Shusuke
    Nomura, Sayaka
    Ohgane, Kenji
    Hashimoto, Yuichi
    Ishikawa, Minoru
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2017, 56 (38) : 11530 - 11533